A surface depends on its structure.
Firmness, flexibility and the ability to hold water come from different parts of skin working together. Collagen fibres resist pulling. Elastic fibres help a stretched surface return. Proteoglycans—proteins carrying long sugar chains—organise this weave and help keep it hydrated.
Together these materials form the extracellular matrix, or ECM: the material outside cells. It is more than packing. A cell senses the matrix around it and changes its behaviour in response. The earlier edition’s discussion of ageing and fibroblast collapse points to this two-way relationship: PubMed record 17015250 and PubMed record 23467542.
Age changes the organisation, too.
Chronological ageing and repeated ultraviolet exposure do not affect skin in exactly the same way. Both can shift the balance between making matrix and breaking it down. Sun-related damage also changes elastic fibres; glycation, a reaction between sugars and proteins, can create unwanted cross-links.
Fibroblasts are cells that make much of the dermal matrix. When collagen becomes fragmented, the cells lose some of the mechanical support that helps maintain their normal activity. More collagen is therefore not the whole research question. Its organisation matters.
Quantity is one measurement. A working weave is another.
Where peptides enter the picture.
A peptide is a short amino-acid chain. Some act as signals; others bind a metal or resemble a fragment released when a larger protein breaks down. These roles help explain interest in GHK-Cu, palmitoyl peptides and collagen hydrolysates.
Research asks whether a compound changes collagen production, matrix-degrading enzymes called metalloproteinases, or the sugars that help hold water. The older topical-peptide and cosmetic-peptide sources are retained here: PubMed record 19368654, PubMed record 16029673 and PubMed record 18505499. Their findings belong to their particular preparations and experiments.
A promising mechanism still has a distance to travel.
Skin penetration, chemical stability and the finished formulation can change an ingredient’s behaviour. Combining peptides also makes attribution harder: a better result from a mixture does not reveal which ingredient caused it. The earlier combination-formulation source remains available as PubMed record 19678854.
Facial skin, the delicate area around the eyes and the neck were prominent subjects in the earlier edition. Its discussion also covered laser procedures, microneedling and other combination treatments. Those are research contexts, not services offered here, and mechanistic arguments cannot establish the safety of putting a formulation through a disrupted skin barrier.
Keep three questions together. Which molecule was tested? In which route or formulation? In what kind of study? Our study-design explainer follows those questions from the laboratory to human measurements.